Pharmaceutical Executive-01-15-2009

Pharmaceutical Executive

Latest Flu Season Sets Tamiflu Back but Doesn't Knock It Down

January 14, 2009

News Analysis

0

0

The Tamiflu-resistant flu strain means increased sales for GSK's Relenza, but doesn't mean the end for the number-one antiviral.

Pfizer Sheds More Staff

January 14, 2009

News Analysis

0

0

Sales reps aren't the only ones heading for the unemployment line - Pfizer is eliminating researcher positions as fewer drugs are making it to development. But could streamlining the crux of drug R&D cause more harm than good?

Nycomed's New Horizons

January 14, 2009

News Analysis

0

0

Long-standing Nycomed CEO Håkan Björklund tells Pharm Exec Europe how the company is looking to new products, and new territories, to combat the patent expiry of its biggest product.